K. Maruyama et al., ELECTROPHYSIOLOGICAL EFFECTS OF RO-22-9194, A NEW ANTIARRHYTHMIC AGENT, ON GUINEA-PIG VENTRICULAR CELLS, British Journal of Pharmacology, 114(1), 1995, pp. 19-26
1 Cardiac effects of Ro 22-9194 were examined in papillary muscles and
single ventricular myocytes isolated from guinea-pigs and compared wi
th those of moricizine. 2 In papillary muscles, both Ro22-9194 (greate
r than or equal to 10 mu M) and moricizine (greater than or equal to 1
mu M) caused a significant dose-dependent decrease in the maximum ups
troke velocity (V-max) and a shortening of the action potential durati
on. 3 In the presence of either drug, trains of stimuli at rates great
er than or equal to 0.2 Hz led to an exponential decline in V-max. Thi
s use-dependent block was enhanced at higher stimulation frequencies.
A time constant (tau R) for V-max,,, recovery from the use-dependent b
lock was 9.3 s for Ro 22-9194 and 26.4 s for moricizine. 4 The curves
relating membrane potential and V-max,, in single myocytes were shifte
d by Ro 22-9194 (30 mu M) or by moricizine (3 mu M) in a hyperpolarizi
ng direction by 8.4 mV and 8.0 mV respectively. 5 In myocytes treated
with Ro22-9194 (30 mu M), a 10 ms conditioning clamp to 0 mV caused a
significant decrease in V-max,, of the subsequent test action potentia
l; further prolongation of the clamp pulse duration resulted in a mode
st enhancement of the V-max inhibition. In the presence of moricizine
(3 mu M), a similar conditioning clamp > 200 ms caused a significant V
-max,, reduction; the longer the clamp pulse duration, the greater the
V-max reduction. 6 Ro 22-9194 greater than or equal to 30 mu M caused
a slight decrease of calcium inward current (I-Ca) of myocytes withou
t affecting the delayed rectifier potassium current (I-K). 7 These fin
dings suggest that the primary electrophysiological effect of Ro 22-91
94 as an antiarrhythmic agent is, like moricizine, a use- and voltage-
dependent inhibition of sodium channels. From the onset and offset kin
etics of the use-dependent block, Ro 22-9194 belongs to the intermedia
te kinetic Class I drugs, while moricizine is a slow kinetic drug. Fro
m the state-dependence of sodium channel block, Ro 22-9194 may belong
to activated channel blockers, while moricizine belongs to inactivated
channel blockers.